Forsta AP Fonden Sells 3,900 Shares of Danaher Corporation $DHR

Forsta AP Fonden trimmed its holdings in shares of Danaher Corporation (NYSE:DHR) by 2.8% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 134,522 shares of the conglomerate’s stock after selling 3,900 shares during the period. Forsta AP Fonden’s holdings in Danaher were worth $30,795,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Norges Bank bought a new position in shares of Danaher during the 4th quarter worth about $2,177,106,000. Eurizon Capital SGR S.p.A. bought a new position in shares of Danaher during the 4th quarter worth about $76,582,000. Triglav Investments D.O.O. lifted its holdings in shares of Danaher by 211.7% during the 4th quarter. Triglav Investments D.O.O. now owns 18,700 shares of the conglomerate’s stock worth $4,281,000 after acquiring an additional 12,700 shares during the period. Fideuram Asset Management Ireland dac bought a new position in shares of Danaher during the 4th quarter worth about $14,247,000. Finally, National Pension Service lifted its holdings in shares of Danaher by 0.5% during the 4th quarter. National Pension Service now owns 1,453,086 shares of the conglomerate’s stock worth $332,640,000 after acquiring an additional 6,725 shares during the period. 79.05% of the stock is owned by institutional investors.

Danaher Trading Up 1.2%

Shares of DHR stock opened at $182.73 on Friday. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80. The company has a market capitalization of $129.33 billion, a P/E ratio of 35.34, a P/E/G ratio of 2.41 and a beta of 0.81. The firm has a 50-day moving average price of $182.11 and a 200 day moving average price of $207.48. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.94 by $0.12. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The firm had revenue of $5.95 billion during the quarter, compared to the consensus estimate of $6 billion. During the same period last year, the firm posted $1.88 EPS. The firm’s quarterly revenue was up 3.7% on a year-over-year basis. Research analysts forecast that Danaher Corporation will post 8.43 earnings per share for the current fiscal year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be given a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 0.9%. The ex-dividend date is Friday, June 26th. Danaher’s dividend payout ratio (DPR) is presently 30.95%.

Analysts Set New Price Targets

A number of research firms have recently commented on DHR. Wolfe Research reduced their price objective on shares of Danaher from $260.00 to $230.00 and set an “outperform” rating for the company in a report on Wednesday, April 8th. TD Cowen reduced their price objective on shares of Danaher from $245.00 to $240.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. JPMorgan Chase & Co. reduced their price objective on shares of Danaher from $275.00 to $245.00 and set an “overweight” rating for the company in a report on Wednesday, April 22nd. Jefferies Financial Group reissued a “buy” rating and set a $245.00 price target on shares of Danaher in a report on Tuesday, April 21st. Finally, UBS Group cut their price target on shares of Danaher from $270.00 to $250.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. Twenty research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $238.24.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.